FDA.reportPublic FDA data

Application 205034

Type
ANDA
Sponsor
AMNEAL PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001VORICONAZOLEVORICONAZOLEFOR SUSPENSION;ORAL200MG/5MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
65162-913VoriconazoleVoriconazoleAmneal Pharmaceuticals LLCANDACurrent
65162-913VoriconazoleVoriconazoleAmneal Pharmaceuticals LLCANDACurrent
65162-913VoriconazoleVoriconazoleAmneal Pharmaceuticals LLCANDACurrent
65162-913VoriconazoleVoriconazoleAmneal Pharmaceuticals LLCANDACurrent
65162-913VoriconazoleVoriconazoleAmneal Pharmaceuticals LLCANDACurrent
65162-913VoriconazoleVoriconazoleAmneal Pharmaceuticals LLANDACurrent
65162-913VoriconazoleVoriconazoleAmneal Pharmaceuticals LLCANDACurrent
65162-913VoriconazoleVoriconazoleAmneal Pharmaceuticals LLCANDACurrent
65162-913VoriconazoleVoriconazoleAmneal Pharmaceuticals LLCANDACurrent
65162-913VoriconazoleVoriconazoleAmneal Pharmaceuticals LLCANDACurrent